<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-3NNE37YQ</identifier><date>2024</date><creator>Dolinar, Patricija</creator><relation>documents/doc/3/URN_NBN_SI_doc-3NNE37YQ_001.pdf</relation><relation>documents/doc/3/URN_NBN_SI_doc-3NNE37YQ_001.txt</relation><format format_type="issue">2</format><format format_type="volume">75</format><format format_type="type">article</format><format format_type="extent">str. 143-149</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">234713347</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-3NNE37YQ</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">farmacevtska skrb</subject><subject language_type_id="slv">implementacija brezšivne skrbi</subject><subject language_type_id="slv">lekarniški farmacevti</subject><subject language_type_id="slv">neželeni učinki</subject><subject language_type_id="slv">oftalmološka zdravila</subject><subject language_type_id="slv">sodelovalnost bolnikov</subject><title>Vloga farmacevta pri svetovanju o uporabi oftalmoloških zdravil</title><title>The pharmacist’s role in advising on the use of ophthalmic medicines</title></Record>